Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra®) anti-Xa activity [1]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 2, 2004, Pages 346-348

  Depasse, F ^a   Gerotziafaz, G T ^a   Busson, J ^a   Van Dreden, P ^b   Samama, M M ^a,c  

^a LCL Clinical Research Department   (France)

^b Serbio Diagnostica Stago   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; CHROMOGENIC SUBSTRATE; POLYSACCHARIDE;

ANALYZER; ANTICOAGULATION; BLOOD CLOTTING PARAMETERS; CALIBRATION; DRUG BLOOD LEVEL; HEMATOLOGICAL PROCEDURES; IC 50; INTERMETHOD COMPARISON; LETTER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; BLOOD CLOTTING TEST; DRUG ANTAGONISM; HUMAN; METHODOLOGY; REPRODUCIBILITY; STANDARD;

BLOOD COAGULATION TESTS; CHROMOGENIC COMPOUNDS; FACTOR XA; HUMANS; POLYSACCHARIDES; REPRODUCIBILITY OF RESULTS;

EID: 4644316829     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7933.2004.0584a.x     Document Type: Letter

References (7)

1. Samama MM, Gerotziafas GT. Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux). Thromb Res 2003; 109: 1-11.
2. Gallus AS, Coghlan DW. Heparin pentasaccharide. Curr Opin Hematol 2002; 9: 422-9.
3. Donat F, Duret JP, Santoni A, Cariou R, Necciari J, Magnani H, De Greef R. The pharmacokinetics of fondaparinux sodium in healthy volunteers. Clin Pharmacokinet 2002; 41 (Suppl. 2): 1-9.
4. The Rembrandt investigators. Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A / ORG31540) with pure anti-factor Xa activity: a phase II evaluation. Circulation 2000; 102: 2726-31.
5. Coussement PK, Bassant JP, Convens C, Vrolix M, Boland J, Grollier G, Michels R, Vahanian A, Vanderheyden M, Rupprecht HJ, Van de Werf F, PENTALYSE investigators. A synthetic factor-Xa inhibitor (ORG31540 / SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE Study. Eur Heart J 2001; 22: 1716-24.
6. ICH Harmonized Tripartite Guideline. Validation of Analytical Procedures: Methodology Q2B, Federal Register 1997; 62 27463-7.
7. Boneu B, Necciari J, Cariou R, Sié P, Gabaig AM, Kieffer G, Dickinson J, Lamond G, Moelker H, Mant T, Magnani H. Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107 / ORG31540) with high affinity to antithrombin III in man. Thromb Haemost 1995; 76: 1468-73.